Publications

Estimating the probability of demonstrating vaccine efficacy in the declining Ebola epidemic: a Bayesian modelling approach.

CAMACHO, A; EGGO, RM; FUNK, S; WATSON, CH; KUCHARSKI, AJ; EDMUNDS, WJ;

2015

BMJ open, (2015).5 12 10.1136/bmjopen-2015-009346.

Cost-effectiveness of a cardiac output-guided haemodynamic therapy algorithm in high-risk patients undergoing major gastrointestinal surgery.

SADIQUE, Z; HARRISON, DA; GRIEVE, R; Rowan, KM; Pearse, RM; OPTIMISE study group,;

2015

Perioperative medicine (London, England), (2015).4 1 10.1186/s13741-015-0024-x.

Quantitative analyses and modelling to support achievement of the 2020 goals for nine neglected tropical diseases.

Hollingsworth, TD; Adams, ER; Anderson, RM; ATKINS, K; Bartsch, S; Basáñez, M-G; Behrend, M; Blok, DJ; CHAPMAN, LA C; Coffeng, L; Courtenay, O; Crump, RE; De Vlas, SJ; Dobson, A; Dyson, L; Farkas, H; Galvani, AP; Gambhir, M; Gurarie, D; Irvine, MA; Jervis, S; Keeling, MJ; Kelly-Hope, L; King, C; Lee, BY; ... NTD Modelling Consortium,

2015

Parasites & vectors, (2015).8 1 10.1186/s13071-015-1235-1.

Age- and Sex-Specific Social Contact Patterns and Incidence of Mycobacterium tuberculosis Infection.

Dodd, PJ; Looker, C; Plumb, ID; BOND, V; SCHAAP, A; Shanaube, K; Muyoyeta, M; VYNNYCKY, E; GODFREY-FAUSSETT, P; CORBETT, EL; Beyers, N; AYLES, H; WHITE, RG;

2015

American journal of epidemiology, (2015).183 2 10.1093/aje/kwv160.

Duration of Ebola virus RNA persistence in semen of survivors: population-level estimates and projections.

EGGO, RM; WATSON, CH; CAMACHO, A; KUCHARSKI, AJ; FUNK, S; EDMUNDS, WJ;

2015

Euro surveillance, (2015).20 48 10.2807/1560-7917.ES.2015.20.48.30083.

Individual-level factors associated with variation in mycobacterial-specific immune response: Gender and previous BCG vaccination status.

RHODES, SJ; KNIGHT, GM; FIELDING, K; Scriba, TJ; Pathan, AA; McShane, H; FLETCHER, H; WHITE, RG;

2015

Tuberculosis (Edinburgh, Scotland), (2015).96, 10.1016/j.tube.2015.10.002.

Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models.

Penny, MA; Verity, R; Bever, CA; Sauboin, C; Galactionova, K; FLASCHE, S; White, MT; Wenger, EA; Van de Velde, N; Pemberton-Ross, P; Griffin, JT; Smith, TA; Eckhoff, PA; Muhib, F; JIT, M; Ghani, AC;

2015

Lancet, (2015).387 10016 10.1016/S0140-6736(15)00725-4.

Ebola virus disease in the Democratic Republic of the Congo, 1976-2014.

Rosello, A; Mossoko, M; FLASCHE, S; VAN HOEK, AJ; Mbala, P; CAMACHO, A; FUNK, S; KUCHARSKI, A; Ilunga, BK; EDMUNDS, WJ; PIOT, P; BAGUELIN, M; Tamfum, J-JM;

2015

eLife, (2015).4 NOVEMB 10.7554/eLife.09015.

Bridging the gap between evidence and policy for infectious diseases: How models can aid public health decision-making.

KNIGHT, GM; Dharan, NJ; Fox, GJ; Stennis, N; Zwerling, A; Khurana, R; Dowdy, DW;

2015

International journal of infectious diseases, (2015).42, 10.1016/j.ijid.2015.10.024.

Modelling the distribution and transmission intensity of lymphatic filariasis in sub-Saharan Africa prior to scaling up interventions: integrated use of geostatistical and mathematical modelling.

Moraga, P; CANO, J; BAGGALEY, RF; Gyapong, JO; Njenga, SM; NIKOLAY, B; Davies, E; Rebollo, MP; PULLAN, RL; Bockarie, MJ; Hollingsworth, TD; Gambhir, M; BROOKER, SJ;

2015

Parasites & vectors, (2015).8 1 10.1186/s13071-015-1166-x.